Semaglutide, Tirzepatide and the Cardiologist: Weight-Directed Therapy as Cardiovascular Therapy. Journal of Heart and Cardiovascular Science, [S. l.], v. 5, n. 1, p. 1–3, 2024. DOI: 10.5281/zenodo.22365904. Disponível em: https://pragmajournals.org/index.php/JHCS/article/view/178. Acesso em: 30 oct. 2026.